Cell therapies for IBD: what works?

Current drug targets

Volumn 14, Issue 12, 2013, Pages 1453-1459

  Ricart, Elena ^a   Jauregui Amezaga, Aranzazu ^b   Ordás, Ingrid ^b   Pinó, Susana ^b   Ramírez, Anna M ^b   Panés, Julián ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL THERAPY; DRUG SCREENING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; TREATMENT OUTCOME;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; DRUG EVALUATION, PRECLINICAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84901384737     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113146660234     Document Type: Review

References (0)